Important role for endothelins in acute hepatic ischemia/Reperfusion injury

Journal of Investigative Surgery

Volumn 14, Issue 1, 2001, Pages 31-45

  Uhlmann, D ^a   Uhlmann, S ^a   Spiegel, H U ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Endothelins; Ischemia; Liver; Microcirculation; Reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BOSENTAN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; LACTATE DEHYDROGENASE; OXYGEN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE MODEL; DRUG SELECTIVITY; ERYTHROCYTE KINETICS; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; LEUKOCYTE ADHERENCE; LIVER CELL DAMAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LIVER SINUSOID; MEDICAL ASSESSMENT; MICROCIRCULATION; NONHUMAN; OXYGEN SUPPLY; OXYGEN TISSUE LEVEL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REPERFUSION; REPERFUSION INJURY; TIME; VASCULARIZATION; VASOCONSTRICTION;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; ASPARTATE AMINOTRANSFERASES; CELL HYPOXIA; ENDOTHELIN-1; FEMALE; L-LACTATE DEHYDROGENASE; LASER-DOPPLER FLOWMETRY; LIVER; LIVER CIRCULATION; MICROCIRCULATION; RATS; RATS, WISTAR; REPERFUSION INJURY; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035102031     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/089419301750072194     Document Type: Article

References (62)

1. Die Rolle des Reperfusionschadens
2. Role of neutrophils during the first 24 hours after liver ischemia and reperfusion injury
3. Preservation and reperfusion injuries in liver allografts
4. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
5. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury
6. Biological actions of endothelin
7. Endothelins: Polyfunctional cytokines
8. The possible role of endothelin in the pathogenesis of coronary vasospasm
9. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats
10. Verringerung des hepatischen Ischamie/Reperfusionsschadens durch kontrollierte Vasoregulation der Lebermikrozirkulation
11. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist
12. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors
13. Evaluation of hepatic microcirculation by in vivo microscopy
14. In vivo fluorescence microscopy for quantitative analysis of the hepatic microcirculation in hamsters and rats
15. Reduction by superoxide dismutase of leukocyte-endothelial adherence after liver transplantation
16. Differential impact of Carolina rinse and University of Wisconsin solution on microcirculation, leukocyte adhesion, Kupffer cell activity and biliary excretion after liver transplantation
17. 2 monitoring in experimental angiology
18. Radioimmunological determination of endothelin peptides in human plasma: A methodological approach
19. Dry reagent technology. Kodak Ektachem 700 XR in clinical enzymology
20. Measurement of hepatic perfusion in rats by laser Doppler flowmetry
21. Endothelium-derived vasoactive substances: Potential role in hypertension, atherosclerosis, and vascular occlusion
22. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide
23. Endothelin and nitric oxide in hepatorenal syndrome: A balance reset
24. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury
25. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
26. Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation
27. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation
28. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances
29. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart
30. Endothelin-1 levels in portal venous blood in relation to hepatic tissue microcirculation disturbances and hepatic cell injury after ischemia/reperfusion
31. Potential roles of endothelin in systemic inflammatory response syndrome with a particular relationship to cytokines
32. Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay
33. Differential effect of anti-TNF-alpha antibody on proinflammatory cytokine release by Kupffer cells following liver ischemia and reperfusion
34. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion
35. Degradation of endothelin-1 by extracts of rat lung, kidney, and liver
36. Purification and characterization of endothelin-1 degradation activity from porcine kidney
37. Characterization of a novel, high-molecular weight, acid, endothelin-1-inactivating metalloendotpeptidase from the rat kidney
38. B receptors
39. Controlled selective vasoregulation of postischemic liver microcirculation-A therapeutic approach
40. Effect of endothelin receptor antagonist bosentan on postischemic liver microcirculation
41. B-receptor antagonist (Ro-47-0203)
42. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells
43. Endothelin-1 induces direct constriction of hepatic sinusoids
44. ET-1 induced alterations of hepatic microcirculation: Sinusoidal and extrasinusoidal sites of action
45. Hepatic sinusoidal cells and sinusoidal circulation
46. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus
47. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients
48. Effect of endothelin-1 on the contraction of Ito cells (fat-storing cells)
49. Hepatic microcirculatory disturbances due to portal vein clamping in the orthotopic rat liver transplantation model
50. 2 in rat liver microcirculation
51. Prevention of cold ischemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation
52. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury
53. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts
54. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors
55. Protective effect of the endothelin antagonist bosentan against ischemic skeletal muscle necrosis
56. Microvascular ischemia-reperfusion injury in striated muscle: Significance of "reflow paradox"
57. Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine
58. Increased endothelin receptor gene expression in hypoxic rat lung
59. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat
60. Influence of hypoxia on hepatic and renal endothelin gene expression
61. 125I]endothelin-1 by liver-derived cells
62. Early midzonal death during low-flow hypoxia in the isolated perfused rat liver: Protection by allupurinol